Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial

This is the accepted manuscript version of the work published in its final form Koudou, G. B., Bjerum, C. M., Ouattara, F. A., Gabo, T. P., Goss, C. W., Lew, D., Dje, N. N., King, C. L., Fischer, P. U., Weil, G. J., & Budge, P. J. (2025). Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(25)00111-2. Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing [email protected].

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-01
DOI
https://doi.org/10.5281/zenodo.15693651
Primary Topic
Parasitic Diseases Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial

Zenodo (CERN European Organization for Nuclear Research)
Parasitic Diseases Research and Treatment
article

Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial

article en

Abstract

This is the accepted manuscript version of the work published in its final form Koudou, G. B., Bjerum, C. M., Ouattara, F. A., Gabo, T. P., Goss, C. W., Lew, D., Dje, N. N., King, C. L., Fischer, P. U., Weil, G. J., & Budge, P. J. (2025). Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(25)00111-2. Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing [email protected].

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 51%
Parasitic Diseases Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS